Literature DB >> 9597082

Regulation of cytokine production by eicosanoids and nitric oxide.

J Marcinkiewicz1.   

Abstract

Cytokines are widely regarded as regulatory molecules of inflammatory and immune reactions. Nevertheless, the details of functioning of the complex cytokine network are not yet fully understood. Recent data indicate that eicosanoids, primarily the products of the inducible form of cyclooxygenase (COX-2), are involved in the regulation of cytokine production. We have shown that prostaglandins of E series are no longer only suppressor molecules but they selectively up- or down-regulate the cytokine production. Similarly, nitric oxide (NO) generated in activated immune cells by inducible isoform of nitric oxide synthase (iNOS), is considered to be an immunoregulatory molecule. In this article we present a new concept of interactions between cytokines, eicosanoids (prostaglandins and leukotrienes) and NO. Finally, the impact of these molecules on the regulation of the immune system is discussed.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9597082

Source DB:  PubMed          Journal:  Arch Immunol Ther Exp (Warsz)        ISSN: 0004-069X            Impact factor:   4.291


  3 in total

1.  Inhibitory activity of constitutive nitric oxide on the expression of alpha/beta interferon genes in murine peritoneal macrophages.

Authors:  E Guillemard; B Varano; F Belardelli; A M Quero; S Gessani
Journal:  J Virol       Date:  1999-09       Impact factor: 5.103

2.  The role of host soluble inflammatory mediators induced by the BCG vaccine for the initiation of in vitro monocyte apoptosis in healthy Brazilian volunteers.

Authors:  Jessica Lima; Mariana Siqueira; Paulo R Z Antas; Thaíze Pedro; Carlos Ponte; Leandro Peres; Suelen Marinho; Luíz R Castello-Branco
Journal:  J Inflamm (Lond)       Date:  2015-10-29       Impact factor: 4.981

3.  A Randomized Placebo Controlled Trial of Ibuprofen for Respiratory Syncytial Virus Infection in a Bovine Model.

Authors:  Paul Walsh; Nicole Behrens; Francisco R Carvallo Chaigneau; Heather McEligot; Karan Agrawal; John W Newman; Mark Anderson; Laurel J Gershwin
Journal:  PLoS One       Date:  2016-04-13       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.